Jennifer Hollywood, PhD, University of Auckland, New Zealand
Could this new drug be better than cysteamine? Since 2020, CRF has awarded $430,422 to Dr. Jennifer Hollywood and her team in New Zealand for a study to test a new version of cysteamine, CF10, along with the drug everolimus, as a superior treatment to cysteamine alone. If this works, the new drug combination would mean less frequent dosing, a reduction in gastrointestinal side effects, and perhaps prevent or delay the need for a kidney transplant. With CRF leading the way, there is hope for an improved treatment for our patient community!
Research Study Lay Abstract